BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND MN1, Q10571, MGCR1-PEN, MGCR1, MGCR, dJ353E16_2, ENSG00000169184, 4330 AND Prognosis
4222 results:

  • 1. [Predicting the effectiveness of organ-preserving treatment of choroidal melanoma using optical coherence tomography data].
    Stoyukhina AS
    Vestn Oftalmol; 2024; 140(2. Vyp. 2):16-20. PubMed ID: 38739126
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
    Liu Z; Yu L; Lai J; Zhang R
    Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
    Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
    Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. S1-Guideline Sebaceous Carcinoma.
    Utikal J; Nagel P; Müller V; Becker JC; Dippel E; Frisman A; Gschnell M; Griewank K; Hadaschik E; Helbig D; Hillen U; Leiter U; Pföhler C; Krönig L; Ziemer M; Ugurel S
    J Dtsch Dermatol Ges; 2024 May; 22(5):730-747. PubMed ID: 38679790
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Low-Level Expression of p-S6 Is Associated with Nodal Metastasis in Patients with Head and Neck Cutaneous Squamous Cell Carcinoma.
    Gómez-de Castro C; Santos-Juanes R; Nuñez-Gómez B; Fernández-Vega I; Vivanco B; Fernández-Velasco A; Reyes-García S; Carrero-Martín J; García-Pedrero JM; Rodrigo JP; González-Vela MDC; Santos-Juanes J; Galache C
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673889
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Identification of an anoikis-related gene signature and characterization of immune infiltration in skin cutaneous melanoma.
    Xu Z; Huang J; Shi W; Qi Y; Yuan F; Lin B
    Medicine (Baltimore); 2024 Apr; 103(17):e37900. PubMed ID: 38669429
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments.
    Gefeller O; Kaiser I; Brockmann EM; Uter W; Pfahlberg AB
    Curr Oncol; 2024 Apr; 31(4):2221-2232. PubMed ID: 38668067
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.
    Ertekin SS; Mangas C; Riquelme-Mc Loughlin C; Carrera C; Malvehy J; Puig S; Podlipnik S
    Acta Derm Venereol; 2024 Apr; 104():adv27571. PubMed ID: 38655656
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification and validation of a costimulatory molecule-related signature to predict the prognosis for uveal melanoma patients.
    Zhao M; Yu Y; Song Z
    Sci Rep; 2024 Apr; 14(1):9146. PubMed ID: 38644411
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
    Nishimura T; Fujimoto H; Fujiwara T; Ito K; Fujiwara A; Yuda H; Itani H; Naito M; Kodama S; Furuhashi K; Yagi A; Saiki H; Yasuma T; Okano T; Tomaru A; Tanigawa M; Yoshida M; Hataji O; Ibata H; D'Alessandro-Gabazza CN; Gabazza EC; Kobayashi T
    Cancer Med; 2024 Apr; 13(8):e7188. PubMed ID: 38629295
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A chest CT-based nomogram for predicting survival in acute myeloid leukemia.
    Yi X; Zhan H; Lyu J; Du J; Dai M; Zhao M; Zhang Y; Zhou C; Xu X; Fan Y; Li L; Dong B; Jiang X; Xiao Z; Zhou J; Zhao M; Zhang J; Fu Y; Chen T; Xu Y; Tian J; Liu Q; Zeng H
    BMC Cancer; 2024 Apr; 24(1):458. PubMed ID: 38609917
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data.
    Hong S; Lee JH; Heo JY; Suh KJ; Kim SH; Kim YJ; Kim JH
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):186. PubMed ID: 38600328
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Characteristics of long-survivor metastatic melanoma after polychemotherapy and interferon: a retrospective study.
    Py C; De Vito C; Tsantoulis P; Kaya G; Labidi-Galy SI; Dietrich PY
    Swiss Med Wkly; 2023 Dec; 153():3504. PubMed ID: 38579317
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
    Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
    Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma.
    Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. 5-Methylcytosine immunohistochemistry for predicting cutaneous melanoma prognosis.
    Meevassana J; Varophas S; Prabsattru P; Kamolratanakul S; Ruangritchankul K; Kitkumthorn N
    Sci Rep; 2024 Mar; 14(1):7554. PubMed ID: 38555324
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD146 as a prognostic marker in breast cancer: A meta-analysis.
    Sharma A; Somasundaram I; Chabaud MB
    J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Case report: A case of Paget disease outside the axillary breast.
    Zhou Z; Zhou B; Wu X; Wei W
    Medicine (Baltimore); 2024 Mar; 103(13):e37541. PubMed ID: 38552095
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis.
    Wu Z; Wang X; Wu H; Du S; Wang Z; Xie S; Zhang R; Chen G; Chen H
    Comput Biol Med; 2024 May; 173():108307. PubMed ID: 38547657
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 212.